Breakthrough in Malaria Vaccine Development as RH5.1/Matrix-MTM Shows Promising Results
A clinical trial has revealed the potential of the RH5.1/Matrix-MTM malaria vaccine candidate to provide effective protection against blood-stage malaria, marking a major milestone in the fight against the disease. The results of a phase 2b clinical trial, published in The Lancet Infectious Diseases, demonstrate that the vaccine is both well-tolerated and effective, particularly in…